News

This article compares sandwich vs competitive assays in ELISA and lateral flow, focusing on format selection, reagent strategy and assay development considerations.

This article explains how biomarker assay development and validation ensure reliable clinical applications through careful assay design, analytical testing, clinical validation, and regulatory alignment.

This article explains verification vs validation in immunoassay and in vitro diagnostics, and why both are essential for assay performance, regulatory compliance, and reliable clinical use.

This article explores sensitivity vs specificity in in vitro diagnostics, and how balancing both is critical for test performance, diagnostic accuracy, and reliable clinical decisions.

Quality control in immunoassay development ensures reliable diagnostic results through calibration standards, internal controls, validation studies, and robust assay monitoring.

This article explores the challenges in developing ADA assays for immunogenicity studies, including sensitivity, drug tolerance, cross-reactivity, and assay interference.

This article explores ADA assay platforms for immunogenicity studies, comparing ELISA, ECL, SPR, multiplex assays and Gyrolab to support platform selection and reliable assay performance

This article explains why organisations outsource immunoassay and ELISA development to gain specialist expertise, improve efficiency, reduce costs, and accelerate product development.

At Fleet Bioprocessing Ltd., we take pride in being a Gyrolab Certified Assay Transfer and Development Partner. Fleet Bioprocessing Ltd. enjoys global recognition for our proficiency in bioconjugation chemistry. Our dedication to excellence has cemented our reputation as leaders in the field, trusted by clients worldwide. This complemented with our assay design expertise allows us to deliver reproducible and cost-effective critical reagents specifically designed for all your

Optimising an ELISA method involves several steps to enhance the accuracy, sensitivity, specificity, and overall performance of the assay. At Fleet Bioprocessing , we have the expertise in immunoassay development to support your specific project, but here are some points to consider. Antibody and antigen selection : Your assay will only ever be as good as the reagents used. Whilst for a novel target the choice of antibody may be limited, where a range of antibodies are availa